文献速递乳腺技术与安全MR

整合MRI衍生表观扩散系数与临床病理特征预测乳腺癌腋窝淋巴结转移的列线图

Nomograms Integrating MRI-derived Apparent Diffusion Coefficient and Clinicopathologic Features for Prediction of Axillary Lymph Node Metastasis in Breast Cancer.
PubMed 文献 · Radiol Imaging Cancer · 2025-01-01

本研究回顾性纳入三家医院2019年5月至2023年5月的961例女性乳腺癌患者,基于治疗前弥散加权成像测得的表观扩散系数(ADC)与临床病理特征构建三个列线图,分别预测治疗前腋窝淋巴结状态、非前哨淋巴结状态及新辅助化疗后腋窝淋巴结状态。三个任务中转移组ADC值均低于非转移组(均P<.05);联合模型在训练队列的AUC分别为0.90、0.74、0.75,在两个外部测试队列中任务1和任务3的AUC为0.82至0.90。

要点

  • 乳腺癌腋窝淋巴结转移组的ADC值低于非转移组,差异有统计学意义(均P<.05)。
  • 联合ADC与临床病理特征的列线图预测腋窝淋巴结转移训练队列AUC为0.90。
  • 预测非前哨淋巴结转移训练队列AUC为0.74,预测新辅助化疗后腋窝淋巴结状态训练队列AUC为0.75。

核心结论

  • 整合ADC值与临床病理特征的列线图在预测乳腺癌患者腋窝淋巴结转移方面表现出良好性能。

研究设计与样本

  • 多中心回顾性研究,纳入三家医院961例女性乳腺癌患者(平均年龄50岁±10),获取治疗前含弥散加权成像的MRI并测量ADC值与临床病理特征,采用单因素和多因素logistic回归筛选独立预测因子并构建三个列线图模型,在训练集和两个外部测试集评估性能。

关键影像表现/征象

  • 三个任务中腋窝淋巴结转移组的ADC值均低于非转移组(均P<.05)。

诊断标准与关键数值

  • 任务1列线图预测腋窝淋巴结转移的AUC在训练队列为0.90、外部测试队列1为0.86、外部测试队列2为0.90。
  • 任务2列线图预测非前哨淋巴结转移的AUC在训练队列为0.74。
  • 任务3列线图预测新辅助化疗后腋窝淋巴结状态的AUC在训练队列为0.75、外部测试队列1为0.82、外部测试队列2为0.84。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Purpose To develop three nomograms integrating apparent diffusion coefficients (ADCs) derived from diffusion-weighted imaging to predict the status of pretreatment axillary lymph nodes (ALNs) (task 1), nonsentinel lymph nodes (task 2), and ALNs after neoadjuvant chemotherapy treatment (task 3) in patients with breast cancer. Materials and Methods Pretreatment MRI scans, including diffusion-weighted images, were retrospectively acquired from patients with breast cancer at multiple centers from May 2019 to May 2023. ADC values and clinicopathologic features were measured. Uni- and multivariable logistic regression analyses were performed to identify independent predictors of ALN metastasis. These predictors were incorporated into nomogram models for each of the three tasks. Model performance was assessed with area under the receiver operating characteristic curve (AUC) analysis in training and two external testing datasets. Results The study included 961 female patients (mean age ± SD, 50 years ± 10) with breast cancer from three hospitals. In the three tasks, the ADC values of the ALN metastasis groups were lower than those of the nonmetastasis groups (all P < .05). The nomogram models combining ADC values and clinicopathologic features demonstrated high predictive performance for each task in the training cohort (task 1: AUC, 0.90; task 2: AUC, 0.74; task 3: AUC, 0.75), external testing cohort 1 (task 1: AUC, 0.86; task 3: AUC, 0.82), and external testing cohort 2 (task 1: AUC, 0.90; task 3: AUC, 0.84). Conclusion Nomograms incorporating ADCs and clinicopathologic features demonstrated good performance in predicting ALN metastasis in patients with breast cancer. Keywords: Breast, MR-Functional Imaging, MR-Diffusion Weighted Imaging, Apparent Diffusion Coefficient, Axillary Lymph Node Metastasis, Nonsentinel Lymph Node Metastasis, Neoadjuvant Chemotherapy, Nonogram Supplemental material is available for this article. © RSNA, 2025.

来源:Radiol Imaging Cancer,查看原文。版权归原作者所有。

引用

  1. Chen H, Wang X, Huang Y, et al. Nomograms Integrating MRI-derived Apparent Diffusion Coefficient and Clinicopathologic Features for Prediction of Axillary Lymph Node Metastasis in Breast Cancer. Radiol Imaging Cancer. 2025. PMID: 40116606. doi:10.1148/rycan.240202

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。